SP1 and lung cancer: In an experimental model published by Zhang et al., the combination of CUR with cisplatinum in lung cancer xenograft murine models effectively demonstrated reduction of Sp-1 binding to CTR1 (copper uptake protein 1) promoters, increasing expression of CTR1 and Sp-1 and, thus, the uptake and sensitivity to cisplatinum in these cells [35].